Renzapride in IBS: is efficacy in the eye of the beholder? - Atlantic Healthcare

HEALTHCARE PROFESSIONALS
CONTACT US

About
Research
Investors
News

Search

HEALTHCARE PROFESSIONALS
CONTACT US

Ford AC (2010)

Alimentary Pharmacology and Therapeutics, 113

Recent Posts

Atlantic Healthcare granted new U.S. composition of matter patent for alicaforsen
25th January 2022
Atlantic Healthcare is honoured to speak at the Middle East Investor Relations Associations Conference, Dubai and Attend the Future Investment Initiative, Riyadh
19th October 2021
Atlantic Healthcare strengthens Board with seasoned industry veterans Robert Dow and Julian Thurston
7th June 2021
Atlantic Healthcare attends virtual Digestive Disease Week®
24th May 2021
Atlantic Healthcare to attend IBD UK conference
26th April 2021

Follow

Privacy Preference Center

Privacy Preferences

Privacy Policy